Charles Schwab
PFE icon

Charles Schwab’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.19B Buy
49,165,032
+1,135,457
+2% +$27.5M 0.21% 84
2025
Q1
$1.22B Sell
48,029,575
-107,429,526
-69% -$2.72B 0.23% 71
2024
Q4
$4.12B Buy
155,459,101
+25,315,159
+19% +$672M 0.76% 23
2024
Q3
$3.77B Buy
130,143,942
+12,864,343
+11% +$372M 0.72% 26
2024
Q2
$3.28B Sell
117,279,599
-4,960,353
-4% -$139M 0.63% 32
2024
Q1
$3.37B Buy
122,239,952
+17,993,520
+17% +$496M 0.78% 20
2023
Q4
$2.99B Buy
104,246,432
+8,473,686
+9% +$243M 0.76% 23
2023
Q3
$3.16B Buy
95,772,746
+9,393,992
+11% +$310M 0.91% 18
2023
Q2
$3.15B Buy
86,378,754
+2,477,573
+3% +$90.4M 0.9% 19
2023
Q1
$3.41B Buy
83,901,181
+10,560,702
+14% +$429M 1.04% 13
2022
Q4
$3.74B Buy
73,340,479
+3,216,573
+5% +$164M 1.21% 5
2022
Q3
$3.07B Buy
70,123,906
+6,001,894
+9% +$263M 1.1% 6
2022
Q2
$3.36B Buy
64,122,012
+4,293,163
+7% +$225M 1.17% 5
2022
Q1
$3.1B Buy
59,828,849
+6,972,650
+13% +$361M 0.93% 11
2021
Q4
$3.12B Sell
52,856,199
-552,544
-1% -$32.6M 0.92% 11
2021
Q3
$2.3B Sell
53,408,743
-1,184,631
-2% -$51M 0.75% 17
2021
Q2
$2.14B Buy
54,593,374
+4,018,496
+8% +$157M 0.71% 18
2021
Q1
$1.83B Buy
50,574,878
+8,565,595
+20% +$310M 0.67% 18
2020
Q4
$1.55B Buy
42,009,283
+2,012,367
+5% +$74.1M 0.61% 21
2020
Q3
$1.47B Buy
39,996,916
+143,779
+0.4% +$5.28M 0.68% 18
2020
Q2
$1.3B Sell
39,853,137
-90,772
-0.2% -$2.97M 0.64% 23
2020
Q1
$1.3B Sell
39,943,909
-83,808
-0.2% -$2.74M 0.77% 17
2019
Q4
$1.57B Buy
40,027,717
+1,177,433
+3% +$46.1M 0.84% 15
2019
Q3
$1.4B Buy
38,850,284
+2,901,403
+8% +$104M 0.82% 15
2019
Q2
$1.56B Buy
35,948,881
+868,839
+2% +$37.6M 0.95% 10
2019
Q1
$1.49B Buy
35,080,042
+592,808
+2% +$25.2M 0.95% 14
2018
Q4
$1.51B Sell
34,487,234
-684,847
-2% -$29.9M 1.15% 7
2018
Q3
$1.55B Buy
35,172,081
+34,502
+0.1% +$1.52M 1.03% 7
2018
Q2
$1.27B Buy
35,137,579
+381,615
+1% +$13.8M 0.93% 10
2018
Q1
$1.23B Buy
34,755,964
+208,748
+0.6% +$7.41M 0.96% 10
2017
Q4
$1.25B Buy
34,547,216
+790,097
+2% +$28.6M 0.99% 9
2017
Q3
$1.21B Buy
33,757,119
+482,461
+1% +$17.2M 1.05% 8
2017
Q2
$1.12B Buy
33,274,658
+2,013,835
+6% +$67.6M 1.05% 8
2017
Q1
$1.07B Buy
31,260,823
+377,404
+1% +$12.9M 1.07% 6
2016
Q4
$1B Buy
30,883,419
+1,914,161
+7% +$62.2M 1.1% 6
2016
Q3
$981M Buy
28,969,258
+1,787,208
+7% +$60.5M 1.15% 5
2016
Q2
$957M Sell
27,182,050
-302,884
-1% -$10.7M 1.2% 5
2016
Q1
$815M Buy
27,484,934
+603,691
+2% +$17.9M 1.07% 7
2015
Q4
$868M Buy
26,881,243
+1,246,902
+5% +$40.3M 1.17% 5
2015
Q3
$806M Sell
25,634,341
-625,918
-2% -$19.7M 1.19% 6
2015
Q2
$881M Sell
26,260,259
-998,918
-4% -$33.5M 1.22% 5
2015
Q1
$948M Buy
27,259,177
+228,874
+0.8% +$7.96M 1.33% 4
2014
Q4
$842M Buy
27,030,303
+1,598,361
+6% +$49.8M 1.26% 5
2014
Q3
$752M Buy
25,431,942
+1,507,341
+6% +$44.6M 1.24% 6
2014
Q2
$710M Buy
23,924,601
+1,283,818
+6% +$38.1M 1.19% 7
2014
Q1
$727M Buy
22,640,783
+2,483,154
+12% +$79.8M 1.3% 5
2013
Q4
$617M Sell
20,157,629
-2,037,937
-9% -$62.4M 1.18% 9
2013
Q3
$641M Buy
22,195,566
+421,390
+2% +$12.2M 1.31% 6
2013
Q2
$605M Buy
+21,774,176
New +$605M 1.35% 7